Company / Working Capital
Phio Pharmaceuticals Corp. Working Capital History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$13.0M
FY2020
5-year range
$1.6M / $13.4M
FY2016-FY2020
Trend
+139.3%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 7 years, ranging from $2M in FY2017 to $13M in FY2018.
Based on SEC 10-K filings.
$13M in FY2020 with a 3-year CAGR of +102.3%.
Declined from $13M to $13M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- +102.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +102.3%, indicating consistent growth.
- In FY2020, working capital increased 139.3% year-over-year.
- Peak working capital was recorded in FY2018.
- Lowest working capital in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $13.0M | +139.3% |
| FY2019 | $5.4M | -59.6% |
| FY2018 | $13.4M | +755.5% |
| FY2017 | $1.6M | -85.2% |
| FY2016 | $10.6M | -16.6% |
| FY2013 | $12.7M | +241.2% |
| FY2012 | $3.7M | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026